has_role organic heterocyclic compound candesartan 0 440.15969 440.463 2-ethoxy-1-({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl)-1H-benzimidazole-7-carboxylic acid C24H20N6O3 SNOMEDCT:372512008 InChI=1S/C24H20N6O3/c1-2-33-24-25-20-9-5-8-19(23(31)32)21(20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29) pubmed:23713902 lincs.smallmolecule:LSM-5903 wikipedia.en:Candesartan HTQMVQVXFRQIKW-UHFFFAOYSA-N hmdb:HMDB0014934 pubmed:24464858 reaxys:6377719 Blopress 2-ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid cas:139481-59-7 kegg.compound:C07468 chebi_ontology A benzimidazolecarboxylic acid that is 1<em>H</em>-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1<em>H</em>-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension. patent:US5196444 patent:EP459136 CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnnn2)cc1 SNOMEDCT:108587008 2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid MESH:C081643 NCIt:C65284 2-ethoxy-1-({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl)-1H-benzimidazole-7-carboxylic acid drugbank:DB00796 CV-11974 kegg.drug:D00522 CHEBI:3347 2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid carboxylic acid drug role